The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis
Open accessAbstract
Background: The CANTOS trial (Canakinumab Antiinflammatory Thrombosis Outcome Study) showed that antagonism of interleukin (IL)–1β reduces coronary heart disease in patients with a previous myocardial infarction and evidence of systemic inflammation, indicating that pathways required for IL-1β secretion increase cardiovascular risk. IL-1β and IL-18 are produced via the NLRP3 inflammasome in myeloid cells in response to cholesterol accumulation, but mechanisms linking NLRP3 inflammasome activation to atherogenesis are unclear. The cholesterol transporters ATP binding cassette A1 and G1 (ABCA1/G1) mediate cholesterol efflux to high-density lipoprotein, and Abca1/g1 deficiency in myeloid cells leads to cholesterol accumulation. Methods: To interrogate mechanisms connecting inflammasome activation with atherogenesis, we used mice with myeloid Abca1/g1 deficiency and concomitant deficiency of the inflammasome components Nlrp3 or Caspase-1/11 . Bone marrow from these mice was transplanted into Ldlr −/− recipients, which were fed a Western-type diet. Results: Myeloid Abca1/g1 deficiency increased plasma IL-18 levels in Ldlr −/− mice and induced IL-1β and IL-18 secretion in splenocytes, which was reversed by Nlrp3 or Caspase-1/11 deficiency, indicating activation of the NLRP3 inflammasome. Nlrp3 or Caspase-1/11 deficiency decreased atherosclerotic lesion size in myeloid Abca1/g1 -deficient Ldlr −/− mice. Myeloid Abca1/g1 deficiency enhanced caspase-1 cleavage not only in splenic monocytes and macrophages, but also in neutrophils, and dramatically enhanced neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques, with reversal by Nlrp3 or Caspase-1/11 deficiency, suggesting that inflammasome activation promotes neutrophil recruitment and neutrophil extracellular trap formation in atherosclerotic plaques. These effects appeared to be indirectly mediated by systemic inflammation leading to activation and accumulation of neutrophils in plaques. Myeloid Abca1/g1 deficiency also activated the noncanonical inflammasome, causing increased susceptibility to lipopolysaccharide-induced mortality. Patients with Tangier disease, who carry loss-of-function mutations in ABCA1 and have increased myeloid cholesterol content, showed a marked increase in plasma IL-1β and IL-18 levels. Conclusions: Cholesterol accumulation in myeloid cells activates the NLRP3 inflammasome, which enhances neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques. Patients with Tangier disease, who have increased myeloid cholesterol content, showed markers of inflammasome activation, suggesting human relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“induction of cholesterol efflux from myeloid cells inhibits NLRP3 inflammasome activation73.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [73]
In the citing paper
“In myeloid cells in which cholesterol efflux pathways have been genetically suppressed, accumulation of unesterified cholesterol in the cellular membranes without cholesterol crystal formation or lysosomal damage contributes to both priming and activation of the NLRP3 inflammasome73.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Self-citationMechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,579
Non-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Self-citation
Cited by
Sorted by citations
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,085
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Neutrophils as regulators of cardiovascular inflammation
Silvestre-Roig, C., Braster, Q., Ortega‐Gómez, A., & Soehnlein, O. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0326-7 · Cited by 627
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
Fidler, T. P., Xue, C., Yalçınkaya, M., Hardaway, B., Abramowicz, S., Xiao, T., Liu, W., Thomas, D. G., Hajebrahimi, M. A., Pircher, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03341-5 · Cited by 479
Self-citationNeutrophil Extracellular Traps Participate in Cardiovascular Diseases
Döring, Y., Libby, P., & Soehnlein, O. (2020) · Circulation Research · doi:10.1161/circresaha.120.315931 · Cited by 421
Neutrophil extracellular traps: from physiology to pathology
Hidalgo, A., Libby, P., Soehnlein, O., Aramburu, I. V., Papayannopoulos, V., & Silvestre-Roig, C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab329 · Cited by 426
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
Rohatgi, A. K., Westerterp, M., von Eckardstein, A., Remaley, A. T., & Rye, K. (2021) · Circulation · doi:10.1161/circulationaha.120.044221 · Cited by 353
Self-citationXue, H., Chen, X., Yu, C., Deng, Y., Zhang, Y., Shen, C., Chen, X., Chen, K., Yang, Y., & Ling, W. (2022) · Circulation Research · doi:10.1161/circresaha.122.321253 · Cited by 283
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice
Wang, W., Liu, W., Fidler, T., Wang, Y., Tang, Y., Woods, B., Welch, C., Cai, B., Silvestre-Roig, C., Ai, D., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313283 · Cited by 262
Self-citationGui, Y., Zheng, H., & Cao, R. Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.845942 · Cited by 258
Josefs, T., Barrett, T. J., Brown, E. J., Quezada, A., Wu, X., Voisin, M., Amengual, J., & Fisher, E. A. A. (2020) · JCI Insight · doi:10.1172/jci.insight.134796 · Cited by 239
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
Speer, T., Dimmeler, S., Schunk, S. J., Fliser, D., & Ridker, P. M. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00621-9 · Cited by 251
Inflammasomes as therapeutic targets in human diseases
Li, Y., Huang, H., Liu, B., Zhang, Y. L., Pan, X., Yu, X., Shen, Z., & Song, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00650-z · Cited by 238
Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
Georgila, K., Vyrla, D., & Drakos, E. (2019) · Cancers · doi:10.3390/cancers11081097 · Cited by 238
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223
Neutrophil intrinsic and extrinsic regulation of NETosis in health and disease
Poli, V., & Zanoni, I. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.10.002 · Cited by 223
Impact of Cholesterol Metabolism in Immune Cell Function and Atherosclerosis
Aguilar-Ballester, M., Herrero-Cervera, A., Vinué, Á., Martínez‐Hervás, S., & Navarro, H. G. (2020) · Nutrients · doi:10.3390/nu12072021 · Cited by 216
Wang, Y., Liu, X., Shi, H., Yu, Y. Q., Yu, Y., Li, M., & Chen, R. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.13 · Cited by 208
The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
Meyers, A. K., & Zhu, X. (2020) · Cells · doi:10.3390/cells9081808 · Cited by 207
Zeng, W., Wu, D., Sun, Y., Suo, Y., Yu, Q., Zeng, M., Gao, Q., Yu, B., Jiang, X., & Wang, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-98437-3 · Cited by 196
The emerging roles of neutrophil extracellular traps in wound healing
Zhu, S., Yu, Y., Ren, Y., Xu, L., Wang, H., Ling, X., Jin, L., Hu, Y., Zhang, H., Miao, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04294-3 · Cited by 202
Self-citationNeutrophil Extracellular Traps and Cardiovascular Diseases: An Update
Bonaventura, A., Vecchié, A., Abbate, A., & Montecucco, F. (2020) · Cells · doi:10.3390/cells9010231 · Cited by 193
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
Pyrillou, K., Burzynski, L. C., & Clarke, M. C. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613170 · Cited by 202
Immune Dysfunction in Uremia 2020
Cohen, G. (2020) · Toxins · doi:10.3390/toxins12070439 · Cited by 178
Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis
He, X., Fan, X., Bai, B., Lu, N., Zhang, S., & Zhang, L. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105447 · Cited by 174
The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis
Moschonas, I. C., & Tselepis, A. D. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.06.919 · Cited by 168
Cholesterol efflux pathways, inflammation, and atherosclerosis
Groenen, A. G., Halmos, B., Tall, A. R., & Westerterp, M. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1925217 · Cited by 175
Self-citationNguyen, M.-A., Wyatt, H., Susser, L., Geoffrion, M., Rasheed, A., Duchez, A., Cottee, M. L., Afolayan, E., Farah, E., Kahiel, Z., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b09679 · Cited by 158
Addressing dyslipidemic risk beyond LDL-cholesterol
Tall, A. R., Thomas, D. G., Gonzalez-Cabodevilla, A. G., & Goldberg, I. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148559 · Cited by 150
Self-citationNovel Insights Into the NLRP3 Inflammasome in Atherosclerosis
Jin, Y. H., & Fu, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012219 · Cited by 153
Fotakis, P., Kothari, V. M., Thomas, D. G., Westerterp, M., Molusky, M. M., Altin, E. S., Abramowicz, S., Wang, N., He, Y., Heinecke, J. W., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313253 · Cited by 156
Self-citationHDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Linton, M. F., Yancey, P. G., Tao, H., & Davies, S. S. (2023) · Circulation Research · doi:10.1161/circresaha.123.321563 · Cited by 159
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis
Leiva, O., AbdelHameid, D., Connors, J. M., Cannon, C. P., & Bhatt, D. L. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.08.011 · Cited by 147
Local cholesterol metabolism orchestrates remyelination
Berghoff, S. A., Spieth, L., & Saher, G. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.01.001 · Cited by 145
Inflammasomes, neutrophil extracellular traps, and cholesterol
Tall, A. R., & Westerterp, M. (2019) · Journal of Lipid Research · doi:10.1194/jlr.s091280 · Cited by 141
Self-citationZhang, X., McDonald, J. G., Aryal, B. K., Canfrán‐Duque, A., Goldberg, E. L., Araldi, E., Ding, W., Fan, Y., Thompson, B. M., Singh, A. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107682118 · Cited by 136
ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis
Chen, X., Guo, X.-C., Ge, Q., Zhao, Y., Mu, H., & Zhang, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3462530 · Cited by 135
Mitochondrial DNA in NLRP3 inflammasome activation
Qiu, Y., Huang, Y., Chen, M., Yang, Y., Li, X., & Zhang, W. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108719 · Cited by 143
Liu, W., Östberg, N. K., Yalçınkaya, M., Dou, H., Endo‐Umeda, K., Tang, Y., Hou, X., Xiao, T., Fidler, T. P., Abramowicz, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155724 · Cited by 130
Self-citationXue, C., Chen, K., Gao, Z., Bao, T., Dong, L., Zhao, L., Tong, X., & Li, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01016-w · Cited by 146
An, N., Gao, Y., Si, Z., Zhang, H., Wang, L., Tian, C., Yuan, M., Yang, X., Li, X., Shang, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01592 · Cited by 124
Self-citationHDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
Bonacina, F., Pirillo, A., Catapano, A. L., & Norata, G. D. (2021) · Cells · doi:10.3390/cells10051061 · Cited by 119
In vivo evidence for extracellular DNA trap formation
Yousefi, S., Simon, D., Stojkov, D., Васильевна, К. А., Karaulov, A. V., & Simon, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2497-x · Cited by 115
NLRP3 inflammasome: The rising star in cardiovascular diseases
Zheng, Y., Li, X., Dong, N., & Li, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.927061 · Cited by 122
Yu, X.-H., Deng, W., Chen, J., Xu, X., Liu, X.-X., Chen, L., Shi, M., Liu, Q.-X., Tao, M., & Ren, K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03263-6 · Cited by 107
Inflammation in atherosclerosis: Lessons and therapeutic implications
Libby, P., & Soehnlein, O. (2025) · Immunity · doi:10.1016/j.immuni.2025.09.012 · Cited by 119
Inflammasomes and Atherosclerosis: a Mixed Picture
Tall, A. R., & Bornfeldt, K. (2023) · Circulation Research · doi:10.1161/circresaha.123.321637 · Cited by 112
Self-citationBarrett, T. J., Distel, E., Murphy, A. J., Hu, J., Garshick, M. S., Ogando, Y., Liu, J. J., Vaisar, T., Heinecke, J. W., Berger, J. S., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.039476 · Cited by 102
Thomas, D. G., Doran, A. C., Fotakis, P., Westerterp, M., Antonson, P., Jiang, H., Jiang, X.-C., Gustafsson, J.-Α., Tabas, I. A., & Tall, A. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.100 · Cited by 109
Self-citationShokoples, B. G., Paradis, P., & Schiffrin, E. L. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315116 · Cited by 104
New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia
Chen, R., Zhang, X., Gu, L., Zhu, H., Zhong, Y., Ye, Y., Xiong, X., & Jian, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692061 · Cited by 105
Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
Ye, J., Li, L., Wang, M., Ma, Q., Tian, Y., Zhang, Q., Liu, J., Li, B., Zhang, B., Liu, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900254 · Cited by 110
Yalçınkaya, M., Fotakis, P., Liu, W., Endo‐Umeda, K., Dou, H., Abramowicz, S., Xiao, T., Libby, P., Wang, N., Tall, A. R., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac189 · Cited by 101
Self-citationOxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency
Dou, H., Kotini, A. G., Liu, W., Fidler, T., Endo‐Umeda, K., Sun, X., Olszewska, M., Xiao, T., Abramowicz, S., Yalçınkaya, M., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056414 · Cited by 96
Self-citationXu, H., She, P., Zhao, Z., Ma, B., Li, G., & Wang, Y. (2023) · Advanced Materials · doi:10.1002/adma.202300439 · Cited by 103
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Yalçınkaya, M., Liu, W., Thomas, L.-A., Olszewska, M., Xiao, T., Abramowicz, S., Papapetrou, E. P., Westerterp, M., Wang, N., Tabas, I. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065344 · Cited by 106
Self-citationNeutrophil extracellular traps: A novel target for the treatment of stroke
Zhao, Z., Pan, Z., Zhang, S., Ma, G., Zhang, W., Song, J., Wang, Y., Kong, L., & Du, G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108328 · Cited by 100
Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
Barbu, E., Popescu, M.-R., Popescu, A.-C., & Balanescu, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020963 · Cited by 96
Chen, X., Chen, S., Pang, J., Huang, R., You, Y., Zhang, H., Xiao, J., Xue, H., & Ling, W. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.023 · Cited by 97
Self-citationColchicine prevents accelerated atherosclerosis in TET2 -mutant clonal haematopoiesis
Zuriaga, M. A., Yu, Z., Matesanz, N., Truong, B. M. T., Ramos-Neble, B. L., Lopez, M., Uddin, M. M., Nakao, T., Niroula, A., Zorita, V., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae546 · Cited by 98
Immunometabolic function of cholesterol in cardiovascular disease and beyond
Yvan‐Charvet, L., Bonacina, F., Guinamard, R., & Norata, G. D. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz127 · Cited by 89
NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
Parsamanesh, N., Moossavi, M., Bahrami, A., Fereidouni, M., Barreto, G. E., & Sahebkar, A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.006 · Cited by 87
Zhu, Y., Xia, X., He, Q., Xiao, Q.-A., Wang, D., Huang, M., & Zhang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1202463 · Cited by 99
Circadian Control of Inflammasome Pathways: Implications for Circadian Medicine
Pourcet, B., & Duez, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01630 · Cited by 88
Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases
Alagarsamy, J., Jaeschke, A., & Hui, D. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179892 · Cited by 86
Bai, R., Lang, Y., Shao, J., Deng, Y., Refuhati, R., & Cui, L. (2021) · ASN NEURO · doi:10.1177/17590914211018100 · Cited by 86
NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe?
Chen, X., Zhang, D., Li, Y., Wang, W., Bei, W., & Guo, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105885 · Cited by 84
Self-citationZhu, L., Liu, Y., Wang, K., & Wang, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102629 · Cited by 89
Self-citationMonocytes and macrophages as protagonists in vascular complications of diabetes
Kanter, J. E., Hsu, C.-C., & Bornfeldt, K. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00010 · Cited by 76
Sun, W., Xu, Y., Yao, Y., Yue, J., Wu, Z., Li, H., Shen, G., Liao, Y., Wang, H., & Zhou, W. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01296-x · Cited by 81
Endo‐Umeda, K., Kim, E., Thomas, D. G., Liu, W., Dou, H., Yalçınkaya, M., Abramowicz, S., Xiao, T., Antonson, P., Gustafsson, J.-Α., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317583 · Cited by 83
Self-citationFrom Mitochondria to Atherosclerosis: The Inflammation Path
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomedicines · doi:10.3390/biomedicines9030258 · Cited by 78
miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages
Nguyen, M.-A., Hoang, H.-D., Rasheed, A., Duchez, A.-C., Wyatt, H., Cottee, M. L., Graber, T. E., Susser, L., Robichaud, S., Berber, İ., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319120 · Cited by 74
Self-citationThe IRG1–itaconate axis protects from cholesterol-induced inflammation and atherosclerosis
Cyr, Y., Bozal, F. K., Durán, J. G. B., Newman, A. A. C., Amadori, L., Smyrnis, P., Gourvest, M., Das, D., Gildea, M. A., Kaur, R., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400675121 · Cited by 79
Self-citationMiller, A. P., Coronel, J., & Amengual, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158635 · Cited by 72
ABC Transporters, Cholesterol Efflux, and Implications for Cardiovascular Diseases
Wang, N., & Westerterp, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_6 · Cited by 71
Self-citationWei, K.-H., Lin, I.-T., Chowdhury, K., Lim, K. L., Liu, K., Ko, T., Chang, Y., Yang, K., & Lai, S.-L. (2023) · eLife · doi:10.7554/elife.84679 · Cited by 73
Hang, L., Peng, Y., Xiang, R., Li, X., & Li, Z. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s231916 · Cited by 68
Anti‐inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy
Li, Y., Zhang, Y., Lu, J., Yin, Y., Xie, J., & Xu, B. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16798 · Cited by 69
HDL Functions—Current Status and Future Perspectives
Endo, Y., Fujita, M., & Ikewaki, K. (2023) · Biomolecules · doi:10.3390/biom13010105 · Cited by 75
NLRP3 inflammasome in cardiovascular diseases: an update
Mo, B., Ding, Y., & Ji, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550226 · Cited by 74
Biochanin A Mitigates Atherosclerosis by Inhibiting Lipid Accumulation and Inflammatory Response
Yu, X.-H., Chen, J., Deng, W., Xu, X., Liu, Q.-X., Shi, M., & Ren, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8965047 · Cited by 63
Lipoproteins in chronic kidney disease: from bench to bedside
Speer, T., Ridker, P. M., von Eckardstein, A., Schunk, S. J., & Fliser, D. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1050 · Cited by 67
Ménégaut, L., Thomas, C., Jalil, A., Julla, J., Magnani, C., Ceroi, A., Basmaciyan, L., Dumont, A., Goff, W. L., Mathew, M. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107665 · Cited by 60
Glycolysis in Innate Immune Cells Contributes to Autoimmunity
Xu, Y., Chen, Y., Zhang, X., Ma, J., Liu, Y., Cui, L., & Wang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920029 · Cited by 64
Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function
Alatshan, A., & Benkő, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630569 · Cited by 58
Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases
Rashidi, M., Wicks, I. P., & Vince, J. E. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.06.005 · Cited by 58
Duan, M., Chen, H., Yin, L., Zhu, X., Novák, P., Lv, Y.-C., Zhao, G., & Yin, K. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00858-8 · Cited by 57
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation
Avondt, K. V., Mäegdefessel, L., & Soehnlein, O. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1678664 · Cited by 56
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation
Tall, A. R. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.004 · Cited by 56
Self-citationInhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe−/− Mice
Tang, Y., Liu, W., Wang, W., Fidler, T. P., Woods, B., Levine, R. L., Tall, A. R., & Wang, N. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06943-9 · Cited by 55
Self-citationIsraelov, H., Ravid, O., Atrakchi, D., Rand, D., Goldman, S. E., Bresler, Y., Twitto‐Greenberg, R., Omesi, L., Zaltsman, S. L., Gosselet, F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01927-w · Cited by 53
Monocytes and macrophages in atherogenesis
Amengual, J., & Barrett, T. J. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000634 · Cited by 53
Javaheri, A., Bajpai, G., Picataggi, A., Mani, S., Foroughi, L., Evie, H., Kovács, A., Weinheimer, C. J., Hyrc, K., Xiao, Q., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127312 · Cited by 53
Shi, R., Zhao, K., Wang, T., Yuan, J., Zhang, D., Xiang, W., Qian, J., Luo, N., Zhou, Y., Tang, B., et al. (2021) · Theranostics · doi:10.7150/thno.66420 · Cited by 52
Jian, X., Liu, Y., Zhao, Z., Zhao, L., Wang, D., & Liu, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109375 · Cited by 51
Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
Jiang, C., Xie, S., Yang, G., & Wang, N. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s344730 · Cited by 49
Self-citation
Metadata
- Authors
- Westerterp, M., Fotakis, P., Ouimet, M., Bochem, A. E., Zhang, H., Molusky, M. M., Wang, W., Abramowicz, S., la Bastide-van Gemert, S., Wang, N., Welch, C. L., Reilly, M. P., Stroes, E. S., Moore, K. J., & Tall, A. R.
- Affiliations
- Division of Molecular Medicine (M.W., P.F., A.E.B., M.M.M., W.W., S.A., N.W., C.L.W., A.R.T.)
- University of Ottawa (CA)
- Amsterdam UMC Location University of Amsterdam (NL)
- Columbia University Irving Medical Center (US)
- Department of Epidemiology (S.l.B-v.G.), University of Groningen, University Medical Center Groningen, The Netherlands
- NYU Langone Health (US)
- Corresponding author
- Westerterp, Marit
- Fotakis, Panagiotis
- ORCID
- Venue
- Circulation
- Published
- 2018-08-28
- Volume
- 138
- Issue
- 9
- Pages
- 898-912
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC6160368
- OpenAlex
- W2795137969
- Cited by
- 331
- References
- 49
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 41 · 2023: 47 · 2022: 45 · 2021: 45 · 2020: 36 · 2019: 28 · 2018: 11
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- University of Ottawa
- York University
- Rijksuniversiteit Groningen
- Universiteit van Amsterdam
- Universitair Medisch Centrum Groningen
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K24HL107643, R01HL113147, R01HL117334, R35HL135799, K99HL130574, R01HL107653, T32HL007343)
- National Center for Research Resources (S10RR027050)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- cholesterol efflux, ABCA1, ABCG1, NLRP3 inflammasome, caspase-1, caspase-11, IL-1β, IL-18, NETosis, atherogenesis, myeloid cells, non-canonical inflammasome, Tangier disease
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 1, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cholesterol, Disease Models, Animal, Humans, Inflammation, Receptors, LDL, Spleen, Tangier Disease, Case-Control Studies, Cytokines, Mice, Knockout, Caspases, Caspase 1, Myeloid Cells, Atherosclerosis, Caspases, Initiator, Plaque, Atherosclerotic, Inflammasomes, ATP Binding Cassette Transporter 1, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
